Cargando…
P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL)
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430976/ http://dx.doi.org/10.1097/01.HS9.0000971396.88082.64 |
| _version_ | 1785091088745234432 |
|---|---|
| author | Munoz, Javier Locke, Frederick Lekakis, Lazaros Eradat, Herbert Tees, Michael de Vos, Sven Nath, Rajneesh Stevens, Don Malik, Shahbaz Popplewell, Leslie Hamadani, Mehdi Oluwole, Olalekan Perales, Miguel-Angel Miklos, David Fisher, Paul Goyal, Lovely Navale, Lynn Kaufman, Gregory Kai, Kazuharu Balakumaran, Arun Neelapu, Sattva |
| author_facet | Munoz, Javier Locke, Frederick Lekakis, Lazaros Eradat, Herbert Tees, Michael de Vos, Sven Nath, Rajneesh Stevens, Don Malik, Shahbaz Popplewell, Leslie Hamadani, Mehdi Oluwole, Olalekan Perales, Miguel-Angel Miklos, David Fisher, Paul Goyal, Lovely Navale, Lynn Kaufman, Gregory Kai, Kazuharu Balakumaran, Arun Neelapu, Sattva |
| author_sort | Munoz, Javier |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430976 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309762023-08-17 P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) Munoz, Javier Locke, Frederick Lekakis, Lazaros Eradat, Herbert Tees, Michael de Vos, Sven Nath, Rajneesh Stevens, Don Malik, Shahbaz Popplewell, Leslie Hamadani, Mehdi Oluwole, Olalekan Perales, Miguel-Angel Miklos, David Fisher, Paul Goyal, Lovely Navale, Lynn Kaufman, Gregory Kai, Kazuharu Balakumaran, Arun Neelapu, Sattva Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430976/ http://dx.doi.org/10.1097/01.HS9.0000971396.88082.64 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Munoz, Javier Locke, Frederick Lekakis, Lazaros Eradat, Herbert Tees, Michael de Vos, Sven Nath, Rajneesh Stevens, Don Malik, Shahbaz Popplewell, Leslie Hamadani, Mehdi Oluwole, Olalekan Perales, Miguel-Angel Miklos, David Fisher, Paul Goyal, Lovely Navale, Lynn Kaufman, Gregory Kai, Kazuharu Balakumaran, Arun Neelapu, Sattva P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) |
| title | P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) |
| title_full | P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) |
| title_fullStr | P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) |
| title_full_unstemmed | P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) |
| title_short | P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) |
| title_sort | p1125: durables responses achieved with anti-cd19 allogeneic car t allo-501/501a in phase 1 trials of autologous car t-naïve patients with relapsed/refractory large b-cell lymphoma (r/r lbcl) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430976/ http://dx.doi.org/10.1097/01.HS9.0000971396.88082.64 |
| work_keys_str_mv | AT munozjavier p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT lockefrederick p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT lekakislazaros p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT eradatherbert p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT teesmichael p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT devossven p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT nathrajneesh p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT stevensdon p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT malikshahbaz p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT popplewellleslie p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT hamadanimehdi p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT oluwoleolalekan p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT peralesmiguelangel p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT miklosdavid p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT fisherpaul p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT goyallovely p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT navalelynn p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT kaufmangregory p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT kaikazuharu p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT balakumaranarun p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl AT neelapusattva p1125durablesresponsesachievedwithanticd19allogeneiccartallo501501ainphase1trialsofautologouscartnaivepatientswithrelapsedrefractorylargebcelllymphomarrlbcl |